Equine Arteritis Virus (EAV) Nucleic Acid Test Kit (Lyophilized)

Equine arteritis virus (EAV) is a significant pathogen in the equine industry, causing a variety of clinical manifestations.

• Respiratory Symptoms: Infected horses often exhibit fever, cough, nasal discharge, and labored breathing. The respiratory mucosa may become inflamed, leading to increased mucus production and potential secondary bacterial infections.

• Reproductive Disorders: In pregnant mares, EAV can cause abortion, stillbirth, or the birth of weak foals. It can also lead to infertility in both mares and stallions by affecting the reproductive organs and functions.

• Skin and Systemic Symptoms: Some infected horses may develop skin lesions, such as edema and petechiae. Systemically, there may be depression, loss of appetite, and reduced performance, which can significantly impact the horse's health and working ability.

clinical application:

• Early and Accurate Diagnosis: The EAV nucleic acid detection reagent enables the rapid and precise identification of EAV in horses showing relevant symptoms, facilitating early diagnosis and timely treatment intervention. It can detect the virus even in the incubation period or when symptoms are mild, improving the chances of successful treatment.

• Epidemic Surveillance and Control: For horse farms and equine breeding facilities, regular use of this reagent for mass screening helps to promptly detect EAV - positive cases. Isolating infected horses in a timely manner can effectively block the spread of the virus within the herd, safeguarding the health of the entire horse population and reducing economic losses caused by disease outbreaks.

• Pre - and Post - Transportation Screening: Before and after horse transportation for events like races, shows, or sales, using the EAV nucleic acid detection reagent for screening is crucial. This ensures that the virus is not introduced into new locations or spread during transit, maintaining the health and safety of horses in different regions.

• Reproductive Health Management: In breeding programs, testing mares and stallions with this reagent can help identify EAV - infected individuals, preventing the transmission of the virus through breeding and protecting the reproductive health of the equine population. It is especially important for maintaining the success of breeding operations and the health of foals.

• Research and Development Support: The reagent provides valuable support for scientific research on EAV. It aids in studying the virus's genetic characteristics, mutation trends, and pathogenic mechanisms. Additionally, it plays a vital role in evaluating the efficacy of new vaccines and antiviral drugs, contributing to the development of more effective prevention and treatment strategies.